• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Complications due to contrast agent administration: what has been confirmed in prevention?].

作者信息

Schönenberger E, Mühler M, Dewey M

机构信息

Klinik für Nieren- und Hochdruckerkrankungen, Medizinische Hochschule Hannover, Hannover, Germany.

出版信息

Internist (Berl). 2010 Dec;51(12):1516-24. doi: 10.1007/s00108-010-2760-9.

DOI:10.1007/s00108-010-2760-9
PMID:21079904
Abstract

Computed tomography (CT) and magnetic resonance imaging (MRI) have been evaluated by internists to be the most important medical innovations. Often, intravenous contrast agent administration is required for answering the clinical questions to CT and MRI. In this review we present an overview of the most common and most important aspects that need to be considered prior to intravenous contrast agent administration. We discuss aspects of renal impairment (contrast-induced nephropathy, nephrogenic systemic fibrosis), allergy-like reactions, hyperthyroidism, and pregnancy and breast-feeding.

摘要

相似文献

1
[Complications due to contrast agent administration: what has been confirmed in prevention?].
Internist (Berl). 2010 Dec;51(12):1516-24. doi: 10.1007/s00108-010-2760-9.
2
[Nephrogenic fibrosing dermopathy and systemic fibrosis as complication of MR contrast media in patients with chronic renal failure].[肾源性纤维化皮肤病和系统性纤维化作为慢性肾衰竭患者使用磁共振造影剂的并发症]
Urologiia. 2008 Sep-Oct(5):63-6.
3
Practical administration of intravenous contrast media in children: screening, prophylaxis, administration and treatment of adverse reactions.儿童静脉造影剂的实际应用:不良反应的筛查、预防、给药及治疗
Pediatr Radiol. 2019 Apr;49(4):433-447. doi: 10.1007/s00247-018-4306-6. Epub 2019 Mar 29.
4
Nephrogenic systemic fibrosis.肾源性系统性纤维化
Magn Reson Imaging Clin N Am. 2009 Feb;17(1):159-67. doi: 10.1016/j.mric.2009.01.003.
5
Imaging patients with renal impairment.对肾功能损害患者进行影像学检查。
Abdom Radiol (NY). 2016 Jun;41(6):1108-21. doi: 10.1007/s00261-016-0709-8.
6
Nephrogenic systemic fibrosis and contrast medium-induced nephropathy: a choice between the devil and the deep blue sea for patients with reduced renal function?肾源性系统性纤维化与造影剂诱导的肾病:肾功能减退患者面临的艰难抉择?
Acta Radiol. 2009 Nov;50(9):965-7. doi: 10.3109/02841850903209218.
7
[Renal failure: diagnostic work-up].[肾衰竭:诊断检查]
J Radiol. 2011 Apr;92(4):299-307. doi: 10.1016/j.jradio.2011.02.020. Epub 2011 Apr 22.
8
Safety of magnetic resonance contrast media: a review with special focus on nephrogenic systemic fibrosis.磁共振造影剂的安全性:特别关注肾源性系统性纤维化的综述
Top Magn Reson Imaging. 2015 Feb;24(1):57-65. doi: 10.1097/RMR.0b013e3182a14e79.
9
[Nephrogenic systemic fibrosis (NSF): Effects of stricter guidelines on the use of contrast media containing gadolinium].[肾源性系统性纤维化(NSF):更严格的含钆造影剂使用指南的影响]
Radiologe. 2011 Oct;51(10):831-2. doi: 10.1007/s00117-011-2229-4.
10
Use of Intravenous Gadolinium-based Contrast Media in Patients with Kidney Disease and the Risk of Nephrogenic Systemic Fibrosis: In Training.
Radiology. 2021 Aug;300(2):279-284. doi: 10.1148/radiol.2021210044. Epub 2021 Jun 1.

引用本文的文献

1
[Drug therapy in interventional radiology].
Radiologe. 2015 Jun;55(6):501-9; quiz 510. doi: 10.1007/s00117-015-2808-x.
2
Delayed cardiac tamponade after open heart surgery - is supplemental CT imaging reasonable?心脏直视手术后延迟性心脏压塞——补充CT成像是否合理?
J Cardiothorac Surg. 2013 Jun 24;8:158. doi: 10.1186/1749-8090-8-158.

本文引用的文献

1
Maternofetal pharmacokinetics of a gadolinium chelate contrast agent in mice.母体-胎儿药代动力学在小鼠的钆螯合物造影剂。
Radiology. 2011 Feb;258(2):455-60. doi: 10.1148/radiol.10100652. Epub 2010 Nov 2.
2
Intravenous contrast medium-induced nephrotoxicity: is the medical risk really as great as we have come to believe?静脉注射造影剂所致肾毒性:其医疗风险真的如我们所认为的那般大吗?
Radiology. 2010 Jul;256(1):21-8. doi: 10.1148/radiol.10092000.
3
[Indications for magnetic resonance imaging in Internal Medicine. When do we really need this technology?].
[内科磁共振成像的适应证。我们何时真正需要这项技术?]
Internist (Berl). 2010 Apr;51(4):451-62. doi: 10.1007/s00108-009-2452-5.
4
[Nephrogenic systemic fibrosis: a rare disease with grave consequences].[肾源性系统性纤维化:一种后果严重的罕见疾病]
Internist (Berl). 2010 Jan;51(1):39-44. doi: 10.1007/s00108-009-2408-9.
5
Systematic review of current guidelines, and their evidence base, on risk of lactic acidosis after administration of contrast medium for patients receiving metformin.系统回顾当前关于接受二甲双胍治疗的患者使用造影剂后发生乳酸酸中毒风险的指南及其证据基础。
Radiology. 2010 Jan;254(1):261-9. doi: 10.1148/radiol.09090690.
6
Repeat contrast medium reactions in premedicated patients: frequency and severity.预先用药患者的造影剂重复反应:频率与严重程度
Radiology. 2009 Nov;253(2):372-9. doi: 10.1148/radiol.2532090465. Epub 2009 Sep 29.
7
Nephrogenic systemic fibrosis: change in incidence following a switch in gadolinium agents and adoption of a gadolinium policy--report from two U.S. universities.肾源性系统性纤维化:钆造影剂更换和采用钆造影剂政策后发病率的变化——来自两所美国大学的报告。
Radiology. 2009 Dec;253(3):689-96. doi: 10.1148/radiol.2533090649. Epub 2009 Sep 29.
8
Sodium bicarbonate for prevention of contrast-induced acute kidney injury: a systematic review and meta-analysis.碳酸氢钠预防对比剂诱导急性肾损伤:系统评价和荟萃分析。
Nephrol Dial Transplant. 2010 Mar;25(3):747-58. doi: 10.1093/ndt/gfp389. Epub 2009 Aug 23.
9
The relative renal safety of iodixanol compared with low-osmolar contrast media: a meta-analysis of randomized controlled trials.与低渗性造影剂相比,碘克沙醇的相对肾脏安全性:一项随机对照试验的荟萃分析。
JACC Cardiovasc Interv. 2009 Jul;2(7):645-54. doi: 10.1016/j.jcin.2009.05.002.
10
Background fluctuation of kidney function versus contrast-induced nephrotoxicity.肾功能的背景波动与对比剂诱导的肾毒性
AJR Am J Roentgenol. 2009 Mar;192(3):711-8. doi: 10.2214/AJR.08.1413.